title: Therapeutic advances and risk factor management: our best chance to tackle dementia?
authors: University of Melbourne, Melbourne, VIC twhc@unimelb.edu.au.
authors: Terence W H
authors: TW
authors: Chong
authors: University of Melbourne, Melbourne, VIC.
authors: Samantha M
authors: SM
authors: Loi
authors: University of Melbourne, Melbourne, VIC.
authors: Nicola T
authors: NT
authors: Lautenschlager
authors: University of Melbourne, Melbourne, VIC.
authors: David
authors: D
authors: Ames
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D001315:Australia / Q000453:epidemiology; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D003704:Dementia / Q000188:drug therapy* / Q000453:epidemiology; D019317:Evidence-Based Medicine; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use; D014943:Global Health; D006801:Humans; D008559:Memantine / Q000627:therapeutic use; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D002800:Cholinesterase Inhibitors; D018691:Excitatory Amino Acid Antagonists; C000600266:aducanumab; C550616:solanezumab; D008559:Memantine